Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-24T14:09:04.815Z Has data issue: false hasContentIssue false

Extrapyramidal reactions from concurrent SSRI and atypical antipsychotic use

Published online by Cambridge University Press:  13 June 2014

Charles F Caley*
Affiliation:
University of Connecticut– School of Pharmacy and Psychopharmacology Consultant, The Institute of Living – Burlingame Center for Psychiatric Research and Education, 400 Washington Street, Hartford, CT 06106-3392, USA
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © Cambridge University Press 1998

References

1.Farragher, B, Walsh, N. Delayed extrapyramidal side-effect on combining paroxetine and risperidone [letter]. Ir J Psych Med 1997; 14: 117.CrossRefGoogle Scholar
2.Leysen, JE, Gommeren, W, Eens, Aet al.Biochemical profile of risperidone, a new antipsychotic. J Pharmacol Exp Ther 1988; 247: 661–70.Google Scholar
3.Bymaster, FP, Calligaro, DO, Falcone, JFet al.Radioreceptor binding profile of the atypical antipsychotic olanazapine. Neuropsychopharmacology 1996; 14: 8796.Google Scholar
4.Baldessarini, RJ, Marsh, E. Fluoxetine and side-effects (letter). Arch Gen Psychiatry 1990; 47: 191–2.CrossRefGoogle Scholar
5.Galey, CF. Extrapyramidal reactions and the selective serotonin reuptake inhibitors. Ann Pharmacother 1997, in print.Google Scholar